Rigel Pharmaceuticals reported $27.4M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acura Pharmaceuticals ACUR:US 523K 138K
Agenus AGEN:US $ 18.95M 3.02M
Amgen AMGN:US $ 1.23B 197M
Anika Therapeutics ANIK:US $ 19.2M 1.23M
Applied Genetic Technologies AGTC:US $ 4.32M 494K
Arrowhead Research ARWR:US $ 33.86M 9.27M
AstraZeneca AZN:LN 3.06B 1.03B
Astrazeneca AZN:US 3.06B 1.03B
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Celldex Therapeutics CLDX:US $ 6.91M 670K
Chemocentryx CCXI:US $ 26.01M 2.72M
Daiichi Sankyo 4568:JP 104.74B 14.78B
Eli Lilly And LLY:US $ 1.56B 34.1M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Immunogen IMGN:US $ 16.65M 3.07M
Intrexon XON:US $ 19.58M 2.81M
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Ligand Pharmaceuticals LGND:US $ 18.18M 444K
Macrogenics MGNX:US $ 16.25M 670K
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Rigel Pharmaceuticals RIGL:US $ 27.4M 2.89M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
Veracyte VCYT:US $ 44.14M 15.82M